Komo Biosciences-preview

Komobiosciences

Komo Biosciences

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://komobiosciences.com/

Last Round

Seed

Jul 9, 2024

Momentum Score

50 /100

Company Overview

Komo Biosciences is a biotechnology company that provides a next-generation precision genome engineering technology for the development and manufacturing of therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

genome engineeringgene integrationintegrase technologylarge payload integrationsite-specific integrationcell line developmentgene writingnon-viral gene deliverynon-nuclease genome engineeringlanding pad technologybiologics manufacturingsynthetic biologycell therapygene therapyagricultural biotechnologyCDMOcontract research and development manufacturing organization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Komo Biosciences Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Komo Biosciences Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 9, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Frank Grazzini

Acting CFO, Co-founder, Acting CFO, Co-founder

Founding Team

Jennifer Manning

Member Board Of Directors, President And Founder CEO

Founding Team

Thomas Page

Chief Technology Officer

Executive Team

Komo Biosciences Investors

Notable investors and investment history

Investor	Rounds
Genesis BioCapital	Seed
Eshelman Ventures	Seed
LDV Partners	Seed
Modi Ventures	Seed
General Inception	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 8, 2025
Monthly visitors grew 75% MoM.
Nov 21, 2024
Monthly visitors grew 89% MoM, reaching 1K.

View all signals

Komo Biosciences Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Komo Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Komo Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range7

Year Founded2024

Last FundingJul 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.